Exploring risk: making the argument for intrapartum CTG monitoring

Does our risk assessment process around CTG monitoring make sense?
Introductory information
Does our risk assessment process around CTG monitoring make sense?
Can we get CTG monitoring to improve outcomes by adding extra bits to it? A summary of what I have previously written.
I’ve written quite a bit about what the research says about CTG use during labour. Here’s a collection of posts for people who want to explore further.
I’ve updated this blog post to include new research findings. (Spoiler: oxygen therapy still doesn’t work)
Synthetic oxytocin can cause fetal hypoxia. Is there evidence about what to do when the CTG becomes abnormal?
Does flipping the woman over fix an abnormal CTG? An evidence summary.
Given IV fluids when the CTG is abnormal is illogical – here’s why.
Are we doing more harm than good when we use a #CTG for a woman with reduced movements?